CATEGORY: DISEASE PREVENTION
Mailing an at-home HPV self-collection kit to patients overdue for cervical cancer screening more than doubled the share who actually got screened. Within six months, 41.1% of those sent a kit had been screened, against 17.4% of patients who received reminder phone calls alone. The randomized trial covered 2,474 patients in a Houston safety-net health system and was published in JAMA Internal Medicine.1 A follow-up call from a patient navigator, on top of the kit, nudged participation a little higher still, to 46.6%.
Why This Particular Screen Can Travel by Mail
Nearly all cervical cancers grow out of a long-lasting infection with HPV, the human papillomavirus, and modern screening works by catching the high-risk types of that virus early. The HPV test is what makes taking part from home possible. A traditional Pap smear needs a clinician to collect cells from the cervix during a pelvic exam. An HPV test can run on a sample a woman collects herself with a simple vaginal swab. The kit goes out by mail, the sample comes back the same way, and the result enters the patient’s record like any other screening test.
Drawn From the Patients Screening Usually Misses
The PRESTIS trial ran inside a publicly funded safety-net system in Houston. It drew a random sample of patients behind on cervical cancer screening, some of them with no screening on record at all. Their median age was 49. Ninety-four percent belonged to racial or ethnic minority groups, and more than half were covered by the county’s financial assistance program. Everyone got a reminder phone call inviting them to clinic-based screening. Which of three groups a patient fell into was settled by a random draw: two groups were also mailed a self-collection kit, and one of those two additionally received a call from a patient navigator, a staff member whose job is to get patients past hurdles like transportation, scheduling and paperwork. The outcome was concrete and checkable, being either attendance for clinic screening or a returned kit within six months, verified through health records.
Seventeen Per Hundred, Then Forty-One
Picture a hundred of these patients getting only the reminder call. About seventeen were screened within six months. Among a hundred who also found a kit in the mailbox, about forty-one were, which is 2.36 times as many, and the trial leaves little imprecision around that figure (95% confidence interval, 1.99 to 2.80). The navigator call carried it to roughly forty-seven per hundred, a gain the researchers themselves describe as modest next to the jump the kit produced. In absolute terms, mailing the kit meant about 24 more people screened for every 100 reached. Houston was not the only place this worked. A separate randomized trial mailed kits to underscreened women aged 30 to 64 across Appalachian Kentucky, Ohio, Virginia and West Virginia, where 14.9% got screened against 5.0% of those sent a conventional reminder letter.2 One caution belongs with both numbers. A returned kit is a first step and not a finish line: a positive HPV result is not a cancer diagnosis, most HPV infections never become cancer, and screening prevents disease only when abnormal results lead to further evaluation.
Key Takeaways
- Mailed HPV self-collection kits raised six-month screening participation to 41.1%, against 17.4% with reminder phone calls alone, or roughly 24 more people screened per 100 reached; a patient navigator call on top of the kit brought it to 46.6%.
- A separate randomized trial in Appalachia produced the same pattern at lower overall participation, 14.9% versus 5.0%, so the finding does not rest on a single health system.
- A returned kit is a screening step rather than a diagnosis: most HPV infections never lead to cancer, and the benefit of screening depends on what follows an abnormal result.
References
- Montealegre JR, Hilsenbeck SG, Bulsara S, et al. Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The PRESTIS Randomized Clinical Trial. JAMA Internal Medicine. 2025;185(9):1119–1127. link
- Reiter PL, Shoben AB, Cooper S, et al. A Mail-Based HPV Self-Collection Program to Increase Cervical Cancer Screening in Appalachia: Results of a Group Randomized Trial. Cancer Epidemiology, Biomarkers & Prevention. 2025;34(1):159–165. link